Richard C. Bethell

Laval, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled Trial.

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled Trial.

Journal: Annals of internal medicine

Published: December 31, 2019

Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia.

Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia.

Journal: Haematologica

Published: May 14, 2019

Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor.

Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor.

Journal: Antimicrobial agents and chemotherapy

Published: February 06, 2015

Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infection.

Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infection.

Journal: Journal of medicinal chemistry

Published: November 14, 2014

Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.

Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.

Journal: Bioorganic & medicinal chemistry letters

Published: July 08, 2014

Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors.

Effects of the W153L substitution in HIV reverse transcriptase on viral replication and drug resistance to multiple categories of reverse transcriptase inhibitors.

Journal: Antimicrobial agents and chemotherapy

Published: May 29, 2014

CD160 isoforms and regulation of CD4 and CD8 T-cell responses.

CD160 isoforms and regulation of CD4 and CD8 T-cell responses.

Journal: Journal of translational medicine

Published: May 06, 2014

Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor.

Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor.

Journal: Antimicrobial agents and chemotherapy

Published: March 26, 2014

Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.

Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.

Journal: ACS medicinal chemistry letters

Published: February 20, 2014

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.

Journal: ACS medicinal chemistry letters

Published: January 03, 2014

Viral resistance in hepatitis C virus genotype 1-infected patients receiving the NS3 protease inhibitor Faldaprevir (BI 201335) in a phase 1b multiple-rising-dose study.

Viral resistance in hepatitis C virus genotype 1-infected patients receiving the NS3 protease inhibitor Faldaprevir (BI 201335) in a phase 1b multiple-rising-dose study.

Journal: Antimicrobial agents and chemotherapy

Published: July 24, 2013

Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series.

Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series.

Journal: Antimicrobial agents and chemotherapy

Published: April 03, 2013

Showing 1-12 of 20

Last Updated: 09/26/2026